Linda Ava
-
32% of US Adults Consumed Fast Food Daily, 2021–2023
One day you’re in a rush. You’ve got a job, kids, a dog flinging mud on your clean walls—and suddenly the drive-thru feels like your only friend. Turns out, you’re not alone. 32% of adults across the US reached the same conclusion on any given day between August 2021 and August 2023. Yep, that’s one […]
-
Disparities in Continuous Glucose Monitor Prescriptions by Language Preference
Did you know non-English language preference (NELP) patients with type 2 diabetes (T2D) are less likely to get continuous glucose monitor (CGM) prescriptions? Yep, even when receiving care at the same clinics as English-speaking patients. That’s not me being dramatic—it’s straight from a study in JAMA Network Open from June 2025. They looked at over […]
-
ADA: Insulin Efsitora Is Noninferior to Glargine For Type 2 Diabetes
You’ve probably heard whispers about this new once-weekly insulin—and yeah, it’s legit. Let me break it down like we’re chatting over coffee: Insulin efsitora (say it slow: eff-SEE-tora) is shaking things up for adults with type 2 diabetes. Recent research from the American Diabetes Association meeting shows it’s just as good at lowering HbA1c as […]
-
Supportive Housing: The Lifeline You’ve Been Hearing About
Okay, let me get real with you. We’re talking about a topic that’s not exactly a picnic in the park: homelessness and opioid use disorder (OUD). Heavy stuff, right? But here’s the kicker—there’s an approach that’s turning heads in the public health world for a really good reason. Supportive housing isn’t just some fancy buzzword; […]
-
Amygdala & Brain Decision-Making: Unraveling Hidden Links
Ever noticed how your brain connects random dots? Like, suddenly hating pineapple pizza because it reminds you of a bad breakup? (Okay, maybe that’s just me.) Turns out, your amygdala—the almond-shaped drama queen nestled deep in your brain—is quietly running the show. A fresh study digs into how this wild thing works, and spoiler: It’s […]
-
SLC13A5 Epilepsy: A Severe Genetic Seizure Condition
Alright, let’s cut to the chase. If you’re here, you’re probably staring down a diagnosis of SLC13A5 epilepsy—or you’re researching for someone who is. Either way, this stuff can feel like looking inside your brain and thinking, “Whoa, what’s broken?” I get it. Your brain’s like a car, and SLC13A5? It’s the gas tank getting […]
-
Majority of Medicaid Cover Naloxone, But Real Access Is Tricky
Let’s get right to it: Yeah, most Medicaid plans cover naloxone—the drug that reverses opioid overdoses. But here’s the kicker: coverage doesn’t always mean you can walk into a pharmacy and grab it. Restrictions, paperwork, and quantity limits still trip people up. Worse? Three states keep it completely off their Medicaid radar. If you’re relying […]
-
Urine-Based Test Helps Personalize Bladder Cancer Treatment
Imagine you’re a bladder cancer patient, someone who’s just finished six weeks of immunotherapy. Your doctor could take months to know if it’s working—leaving you stuck in that worst-case-scenario fog. But now, a simple urine test might cut through the clouds and show the true picture. This isn’t sci-fi. Researchers in 2025 used a urine […]
-
Evidence Lacking for New Neurosteroid Drugs in Treating Postnatal Depression
You know that feeling when you’re handed a parenting manual that says everything will magically fall into place after your baby arrives? Right? If you’re a new parent, you’re probably snorting coffee through your nose right now. Because here’s the truth: postnatal depression (PPD) feels less like a manual and more like a choose-your-own-adventure book […]
-
Study Highlights Chemoimmunotherapy for Lung Cancer in Stage III
Okay, let me cut to the chase. If you or someone you love is navigating aggressive stage III non-small cell lung cancer (NSCLC), you’re probably wondering, “What now? Can anything really make a dent in this?” I get it. It feels like you’re up against a wall sometimes. But here’s the news I’ve been chewing […]